Open label extension studies: research or marketing?

被引:43
作者
Taylor, GJ [1 ]
Wainwright, P
机构
[1] Univ Bath, Sch Hlth, Res & Dev Support Unit, Bath BA1 3NG, Avon, England
[2] Kingston Univ, Fac Hlth & Social Care Sci, London, England
[3] St George Hosp, Sch Med, London, England
来源
BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7516期
关键词
D O I
10.1136/bmj.331.7516.572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:572 / 574
页数:3
相关论文
共 4 条
[1]   Can keeping clinical trial participants blind to their study treatment adversely affect subsequent care? [J].
Blader, JC .
CONTEMPORARY CLINICAL TRIALS, 2005, 26 (03) :290-299
[2]  
Council for International Organizations of Medical Sciences, 2002, INT ETH GUID BIOM RE
[3]   The ethical problems of the open label extension study [J].
Micetich, KC .
CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 1996, 5 (03) :410-414
[4]   Consent to open label extension studies: some ethical issues [J].
Wainwright, P .
JOURNAL OF MEDICAL ETHICS, 2002, 28 (06) :373-376